FDA Assessing Capability To Boost Surveillance Of Indian, Chinese OTC Firms
This article was originally published in The Tan Sheet
Executive Summary
FDA is gathering information that targets tightening regulation of Indian and Chinese OTC, nutritional and traditional medicine manufacturers that use a registration loophole to export products to the U.S. under less stringent oversight.